Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceutical symbols : VTRS save search
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
Published: 2023-10-10 (Crawled : 10:00) - biospace.com/
VTRS | $11.15 -1.5% 2.3M
|
Health Technology
|
| O: 0.93%
H: 0.1%
C: -1.33%
duphaston acquire agreement
Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan
Published: 2022-12-13 (Crawled : 10:00) - biospace.com/
VTRS | $11.15 -1.5% 2.3M
|
Health Technology
|
| O: 1.89%
H: 0.88%
C: -0.09%
CALT | $18.95 4.7K
|
Health Technology
|
| O: 4.72%
H: 1.19%
C: -0.88%
nephropathy japan license therapeutics agreement therapy
Theravance Biopharma, Inc. Announces Enrollment of First Patient in YUPELRI® Phase 4 Study
Published: 2022-01-10 (Crawled : 12:00) - biospace.com/
VTRS | $11.15 -1.5% 2.3M
|
Health Technology
|
| O: 1.58%
H: 1.62%
C: 1.62%
enroll
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Published: 2021-09-15 (Crawled : 12:00) - biospace.com/
VTRS | $11.15 -1.5% 2.3M
|
Health Technology
|
| O: -0.44%
H: 1.17%
C: 0.81%
TBPH | $9.75 1.46% 99K
|
Health Technology
|
| O: -19.15%
H: 15.54%
C: 4.15%
INVA | $14.415 0.1% 120K
|
Health Technology
|
| O: 0.2%
H: 0.4%
C: -0.53%
disease biopharma respiratory
Gainers vs Losers
| 53% | 47% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.